Tetsu Tomita

527 total citations
40 papers, 404 citations indexed

About

Tetsu Tomita is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Tetsu Tomita has authored 40 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 14 papers in Experimental and Cognitive Psychology and 14 papers in Psychiatry and Mental health. Recurrent topics in Tetsu Tomita's work include Treatment of Major Depression (17 papers), Mental Health Research Topics (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Tetsu Tomita is often cited by papers focused on Treatment of Major Depression (17 papers), Mental Health Research Topics (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Tetsu Tomita collaborates with scholars based in Japan, Russia and China. Tetsu Tomita's co-authors include Norio Sugawara, Norio Yasui‐Furukori, Sunao Kaneko, Norio Yasui‐Furukori, Ayako Kaneda, Taku Nakagami, Kazuhiko Nakamura, Yasushi Sato, Akira Fujii and Hanako Furukori and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Tetsu Tomita

38 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsu Tomita Japan 11 121 95 69 64 55 40 404
J.M. Hegeman Netherlands 9 127 1.0× 52 0.5× 62 0.9× 90 1.4× 84 1.5× 11 412
Chi-Un Pae United States 9 106 0.9× 130 1.4× 38 0.6× 144 2.3× 62 1.1× 11 560
Henk Temmingh South Africa 13 207 1.7× 64 0.7× 39 0.6× 128 2.0× 53 1.0× 21 451
Sriram Ramaswamy United States 12 120 1.0× 41 0.4× 74 1.1× 129 2.0× 63 1.1× 33 446
Zeeshan Mansuri United States 14 153 1.3× 42 0.4× 69 1.0× 138 2.2× 35 0.6× 80 492
Alexandria S. Coles Canada 8 136 1.1× 57 0.6× 170 2.5× 104 1.6× 48 0.9× 14 457
Ganpat Vankar India 12 135 1.1× 64 0.7× 37 0.5× 158 2.5× 39 0.7× 36 635
Mohit Chauhan United States 12 153 1.3× 52 0.5× 39 0.6× 116 1.8× 35 0.6× 31 441
Anita S. Kablinger United States 14 216 1.8× 41 0.4× 78 1.1× 133 2.1× 50 0.9× 50 641
Mugdha Thakur United States 8 127 1.0× 79 0.8× 58 0.8× 46 0.7× 107 1.9× 10 420

Countries citing papers authored by Tetsu Tomita

Since Specialization
Citations

This map shows the geographic impact of Tetsu Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsu Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsu Tomita more than expected).

Fields of papers citing papers by Tetsu Tomita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsu Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsu Tomita. The network helps show where Tetsu Tomita may publish in the future.

Co-authorship network of co-authors of Tetsu Tomita

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsu Tomita. A scholar is included among the top collaborators of Tetsu Tomita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsu Tomita. Tetsu Tomita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Maki, Kaori Iino, Takashi Ozaki, et al.. (2025). Characteristics of eclampsia not preceded by hypertensive disorders of pregnancy: a case control study. BMC Pregnancy and Childbirth. 25(1). 774–774.
2.
Saruwatari, Junji, Tetsu Tomita, Shoko Tsuchimine, et al.. (2025). A MODELING APPROACH TO THE THERAPEUTIC EFFECT OF PAROXETINE FOR DEPRESSION WITH A FOCUS ON PHARMACOKINETICS- PHARMACODYNAMICS RELATIONSHIP. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i189–i190.
3.
Tomita, Tetsu, Miki Nishimura, Tetsuya Kaneko, et al.. (2025). Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic‐Pharmacodynamic and Machine Learning Analyses. CPT Pharmacometrics & Systems Pharmacology. 14(6). 1119–1127. 1 indexed citations
4.
Tomita, Tetsu, et al.. (2022). Two Patients with Schizophrenia Treated with Clozapine Developed Neutropenia After Receiving a COVID-19 Vaccine. SHILAP Revista de lepidopterología. 6 indexed citations
5.
Kishi, Kiyohiko, et al.. (2019). Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Tomita, Tetsu, Norio Sugawara, Akira Fujii, et al.. (2018). Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation. Neuropsychiatric Disease and Treatment. Volume 14. 505–510. 7 indexed citations
7.
Sugawara, Norio, Kazuma Danjo, Hanako Furukori, et al.. (2017). Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan. Neuropsychiatric Disease and Treatment. Volume 13. 779–784. 51 indexed citations
8.
Tomita, Tetsu, et al.. (2016). Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV. Neuropsychiatric Disease and Treatment. Volume 12. 2503–2508. 6 indexed citations
9.
Oniki, Kentaro, Tetsu Tomita, Shoko Tsuchimine, et al.. (2016). Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study. Psychiatry Research. 239. 190–195. 8 indexed citations
10.
Tomita, Tetsu, et al.. (2016). Insomnia in patients on hemodialysis for a short versus long duration. Neuropsychiatric Disease and Treatment. Volume 12. 2293–2298. 7 indexed citations
11.
Metoki, Norifumi, Norio Sugawara, Joji Hagii, et al.. (2016). Relationship between the lesion location of acute ischemic stroke and early depressive symptoms in Japanese patients. Annals of General Psychiatry. 15(1). 12–12. 27 indexed citations
12.
Tomita, Tetsu, Norio Yasui‐Furukori, Norio Sugawara, et al.. (2015). The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis. Neuropsychiatric Disease and Treatment. 11. 2935–2935. 3 indexed citations
13.
Tomita, Tetsu, Yasushi Sato, Taku Nakagami, et al.. (2015). Effects of Age on Paroxetine Efficacy in Patients With Major Depressive Disorder Who Do Not Exhibit an Early Response to Treatment. Clinical Neuropharmacology. 38(1). 6–10. 1 indexed citations
14.
Yasui‐Furukori, Norio, Tetsu Tomita, Norio Sugawara, et al.. (2015). The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan. Neuropsychiatric Disease and Treatment. 11. 2811–2811. 5 indexed citations
15.
Tomita, Tetsu, Norio Yasui‐Furukori, Taku Nakagami, et al.. (2014). Therapeutic Reference Range for Plasma Concentrations of Paroxetine in Patients With Major Depressive Disorders. Therapeutic Drug Monitoring. 36(4). 480–485. 18 indexed citations
16.
Tomita, Tetsu, Norio Yasui‐Furukori, Taku Nakagami, et al.. (2014). The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder. PLoS ONE. 9(5). e98099–e98099. 14 indexed citations
17.
Sugawara, Norio, Norio Yasui‐Furukori, Kazuma Danjo, et al.. (2014). Relationship between occupational stress and depression among psychiatric nurses in Japan. Archives of Environmental & Occupational Health. 71(1). 10–15. 64 indexed citations
18.
Tomita, Tetsu, Norio Yasui‐Furukori, & Sunao Kaneko. (2013). Visual Hallucinations During Duloxetine Treatment in a Patient With Major Depressive Disorder. Clinical Neuropharmacology. 36(5). 170–172. 5 indexed citations
19.
Yasui‐Furukori, Norio, et al.. (2013). Interaction between paliperidone extended release and TS-1®, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient. Neuropsychiatric Disease and Treatment. 9. 317–317. 5 indexed citations
20.
Yasui‐Furukori, Norio, Shoko Tsuchimine, Taku Nakagami, et al.. (2011). Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder. Human Psychopharmacology Clinical and Experimental. 26(3). 194–200. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026